VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Axelia Oncology

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 78 out of 100

Harnessing the Innate Immune System to Combat Checkpoint-Insensitive Tumors

  • Biotech & therapeutics
Business model
B2B
Headquarters
Australia
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Biopharmaceutical company aiming to transform the treatment of checkpoint insensitive cancers through the activation of TLR2/6 engagement of the innate immune response.

Products

Web
AXA-042
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy